Abstract In humans, proarrhythmia during therapy with action potential-prolonging drugs can be associated with hypokalemia often provoked by concomitant administration of diuretic agents. Consequently, therapy with class III antiarrhythmics and K'-sparing diuretics, such as triamterene, may be indicated. Triamterene, along with its K'-sparing properties, exhibits other pharmacological effects. In the heart, it can increase action potential duration (guinea pig atria and papillary muscles), protect against reperfusion-induced arrhythmias (rat), and increase the QT interval (humans the slow component of IK (IE) was decreased 36±6% (n=6) and 51±8% (n=6) by triamterene 10-5 and 10`mol/L, respectively. After low-voltage short pulses (-20 mV; 250 milliseconds), tail current amplitude corresponding essentially to the rapid component of IK ('Kr) was decreased only 14±11% (n=9) and 19+10% (n=10) by triamterene 10-5 and 10-4 mol/L, respectively. These results were confirmed under conditions of pure IKS (block of IK, by E-4031) and pure IKr (block of Isi with nisoldipine, extracellular Ca 2+ decreased to virtually 0 mmol/L, and 250-millisecond depolarizing pulse to -20 mV). In contrast, triamterene had no effects on time-independent currents. Thus, data obtained indicate that triamterene, at clinically relevant concentrations, inhibits IKS in a selective manner, although both components of IK (IKr and IKS) were decreased. This block of 'K may explain triamterene-related prolongation of cardiac repolarization and warn about potential drug interaction with action potential-prolonging agents.
R 5 ecently, interest has been focused on the development of antiarrhythmic agents able to selectively prolong refractoriness through a lengthening of cardiac repolarization.1-3 Newly developed drugs with this so-called class III electrophysiological property have shown effectiveness in the prevention of ventricular arrhythmias in several animal models and in humans.4-1 However, previous electrophysiological studies have established that pronounced lengthening of cardiac repolarization can lead to arrhythmia aggravation and to proarrhythmic events. 12, 13 Potassium currents responsible for limiting cardiac action potential duration vary depending on species and cell types. In guinea pig ventricular myocytes, potassium outward currents involved in the repolarization phase of the action potential are the delayed rectifier (IK), the inward rectifier (IK1), and the plateau (IKP) currents. [14] [15] [16] [17] The delayed rectifier potassium current of guinea pig ventricular myocytes is described by a rapidly (IKr) and a slowly (IKS) activating component.18 Relative contributions of IKr and IKS to an activating current elicited by a depolarizing pulse from a holding potential negative to -40 mV depend on both pulse duration and voltage. The ratio is proposed to favor IKr during short depolarizations at low voltages and to favor IKS during long depolarizations to high voltages.
Triamterene is a potassium-sparing agent used concomitantly with thiazide diuretics to prevent excessive potassium losses. 19 After oral administration in humans, peak plasma concentrations of triamterene reach 1 to 2 ,g/mL (4 to 8 gmol/L).20 The exact mechanism of action of triamterene is not well understood, but it has been proposed that, in the kidneys, triamterene reduces electrical potential gradient across tubular epithelium (which represents the basis of renal potassium excretion) by interrupting electrogenic sodium transport. 21 Studies have pointed out that triamterene also exhibits nonrenal pharmacological properties. [22] [23] [24] In the heart, triamterene increases refractory periods of electrically driven isolated guinea pig atria and papillary muscles. 23 Triamterene can also reduce the incidence and duration of arrhythmias induced by either cardiac glycoside toxicity25 or reperfusion of ligated rat coronary artery. 26 Moreover, it has been reported that triamterene can increase the QT interval independently of plasma potassium concentration in humans. 27 The mechanisms by which triamterene exhibits cardiac electrophysiological effects are unknown. In this article, we present effects of triamterene on time-and voltage-dependent potassium currents involved in the 
Protocols
Rod-shape cells with clear cross-striations, resting potential of at least -78 mV, and stable IK (during short and long pulses) and lKl currents (as assessed during a baseline period of at least 4 minutes) were used to study the effects of triamterene. Effects of triamterene on the 'Kr and IK, components of 'K were studied in cells held at -40 mV (to inactivate INa) and depolarized by pulses lasting either 250 (Iso) or 5000 (IK500) milliseconds. Test potentials of depolarizing pulses varied between -20 and +50 mV. IK was measured from the peak magnitude of tail current obtained on repolarization to -30 mV. Repolarizing currents were also assessed by the envelope-of-tails test of IK. In this protocol, pulse duration varied from 30 to 1230 milliseconds by increments of 200 milliseconds, and tail currents, measured on repolarization to -30 mV, were compared with corresponding activating currents elicited after depolarizing pulses to +40 mV. Finally, a voltage ramp was used to obtain the current-voltage (I-V) relation of the lK1. In this protocol, cells were held at -40 mV before their membrane potential was changed from 0 to -100 mV in 500 milliseconds.
Data Storage and Analysis
Currents were filtered at either 2 kHz (IK250 and IKI protocols) or 100 Hz (IK5OO protocol) by a four-pole Bessel filter (-3 dB per octave). Currents were sampled at 4 kHz (IK1), 2 
Results
Fig 1A shows the membrane currents elicited by a 5000-millisecond voltage-clamp step from holding potential (-40 mV) to +40 mV followed by a 5000-millisecond repolarizing pulse to -30 mV. A time-dependent outward current activated during depolarization and complete deactivation of the tail current was observed during repolarization to -30 mV. Superfusion of the cell with triamterene 10`4 mol/L reduced the amplitude of 1K5OOO activating and tail currents.
In the same cell, a 250-millisecond voltage-clamp step from holding potential (-40 mV) to -10 mV activated a steadily increasing (time-dependent) outward current (Fig 1B) . This current deactivated after repolarization to -30 mV. During superfusion of the cell with triamterene 10`mol/L, the amplitudes of 1K250 time-dependent activating and deactivating currents were almost unaffected. Fig 2A illustrates Experiments were performed in the presence of E-4031 to eliminate IKr and to assess more specifically the voltage dependence and extent of block of IKS by triamterene. Records presented in Fig 3 clearly indicate that under these conditions, no time-dependent current was activated for pulses to voltages <0 mV. During long pulses (5000 milliseconds), triamterene 10`4 mol/L caused a voltage-independent decrease in IKS of about 50% (Fig 4) . This value is similar to that obtained in experiments performed without E-4031 (Fig 2A) . During short pulses, the extent of inhibition of IK, was similar (=50%; Fig 5) at voltages at which the current activates (>0 mV). A summary of the results obtained in a series of four cells is presented in Fig 6A and 6B .
These data suggest that block of Ily by triamterene is voltage independent and time independent.
To better quantify the extent of block of triamterene on lKr, further experiments were performed using nisol- (Fig 2B) . The effects of triamterene on lK were also assessed by an envelope-of-tails test (Fig 8) . Neither under control nor in the presence of triamterene was the envelope-oftails test verified. Nevertheless, triamterene caused an increase in the ratio of IKtail/1Kact current for all pulse durations to +40 mV, consistent with a greater block of lyS by the drug.
Reversal of triamterene-induced decrease in 1K25o or IKSOO was never complete; this was more apparent at higher concentrations of the drug (Table 1) . Although some reversal of the effect was observed, no definite conclusions could be drawn on the magnitude of the drug-related decrease in IK because of the potential rundown of IK. To ascertain that the decrease of IK induced by triamterene was not due to rundown of the currents, new series of experiments were undertaken. In these experiments, triamterene 10-4 mol/L was introduced, in a blinded manner, either in the first or in the second perfusion period. An increase in IK induced by superfusion with the second solution was interpreted as a reversal of block, whereas a decrease in IK was indicative of current block. In all cells tested (n= 11), the solution containing triamterene was recognized by the blinded investigator because of noticeable increase or decrease in IK on superfusion with the second solution.
Finally, triamterene (n=23, see Table 2 ) did not significantly alter the maximum positive amplitude of the background current, the voltage corresponding to this peak amplitude, or the reversing potential of this current, which corresponds to the resting potential of the cell. Fig 9 represents Data obtained in this study showed that triamterene decreases 'K elicited during 5000-millisecond depolarizing pulses in a concentration-dependent but voltageindependent manner. For all voltages tested (-10 to +50 mV), inhibition reaches =50% at 10-4 mol/L.
Under conditions in which lK, was eliminated (E-4031), the time-dependent outward current elicited by long pulses to -10 mV and more positive potentials (at which IKS is activated) was also decreased =50% by triamterene 10-4 mol/L. During short pulses, virtually no time-dependent current could be measured at -20, -10, and 0 mV in the presence of E-4031. At more positive potentials (at which IKS is measurable), the decrease of IKS induced by triamterene was similar to that measured during long pulses. Therefore, our results indicate that triamterene inhibits IKS of guinea pig ventricular myocytes in a voltage-and time-independent but concentration-dependent manner (17% at 10`6 mol/L, 34% at 10-5 mol/L, and 52% at 10-4 mol/L).
In initial experiments (cells exposed to Cd2`in the absence of E-4031), triamterene 10-5 and 10-4 mol/L caused a concentration-and apparently voltage-dependent decrease of K20o 
